In an insured population with advanced lung cancer, clinical trial participants had lower or similar total health care costs compared with nonparticipants.
|Articles|July 1, 2000
Supplements and Featured Publications
- Overactive Bladder: Examining the Burden of Disease
- Volume 6
- Issue 11 Suppl
Introduction: Overactive Bladder - Defining the Disease
Author(s)Alan J. Wein, MD
Advertisement
Articles in this issue
over 26 years ago
Discussionover 26 years ago
Bibliographyover 26 years ago
Participating Facultyover 26 years ago
The Prevalence of Overactive Bladderover 26 years ago
Comorbidities Associated with Overactive Bladderover 26 years ago
Overactive Bladder Significantly Affects Overall Quality of Lifeover 26 years ago
Economic Considerations in Overactive BladderAdvertisement
Related to this article
Advertisement
Advertisement
Trending on AJMC
1
NYC Marathon Death Puts Rhabdomyolysis Risk Factors in Focus
2
Real-World Evidence, Rare Liver Disease Data Headline Kidney Week 2026
3
Cranberry Supplement Tied to Greater OAB Score Reductions in Pilot Trial
4
Disease Extent Linked to Complications After Deep Endometriosis Surgery
5